VSPPLTLGQLLS
VSPPLTLGQLLS is a small peptide FGFR3 inhibitor, peptide P3, inhibits FGFR3 phosphorylation. VSPPLTLGQLLS inhibits 9-cisRA-induced tracheal lymphangiogenesis and blocks lymphatic endothelial cell (LEC) proliferation, migration, and tubule formation[1][2].
Product Specifications
CAS Number
1206896-24-3
UNSPSC
12352209
Target
FGFR
Type
Peptides
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/vsppltlgqlls.html
Purity
98.81
Solubility
H2O : 50 mg/mL (ultrasonic)
Smiles
OC[C@@H](C(O)=O)NC([C@H](CC(C)C)NC([C@H](CC(C)C)NC([C@H](CCC(N)=O)NC(CNC([C@H](CC(C)C)NC([C@H]([C@H](O)C)NC([C@H](CC(C)C)NC([C@H]1N(C([C@H]2N(C([C@H](CO)NC([C@H](C(C)C)N)=O)=O)CCC2)=O)CCC1)=O)=O)=O)=O)=O)=O)=O)=O
Molecular Formula
C56H97N13O17
Molecular Weight
1224.45
References & Citations
[1]Perrault DP, et al. Small Peptide Modulation of Fibroblast Growth Factor Receptor 3-Dependent Postnatal Lymphangiogenesis. Lymphat Res Biol. 2019 Feb;17 (1) :19-29. |[2]Jin M, et al. A novel FGFR3-binding peptide inhibits FGFR3 signaling and reverses the lethal phenotype of mice mimicking human thanatophoric dysplasia. Hum Mol Genet. 2012 Dec 15;21 (26) :5443-55.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LS027315-100ug 100 µg
PGAP2 (NM_014489) Human Over-expression Lysate
Sign In for Pricing
View Details 